Guillermo J Ruiz-Arguelles

Summary

Country: Mexico

Publications

  1. ncbi Multiple myeloma in Mexico: a 20-year experience at a single institution
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Calle 8B Sur 3710, 72530 Puebla, Mexico
    Arch Med Res 35:163-7. 2004
  2. ncbi Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Am J Hematol 82:400-2. 2007
  3. ncbi Results of an autologous noncryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single-institution, 10-year experience
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Acta Haematol 110:179-83. 2003
  4. doi Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna de puebla, Laboratorios Clinicos de Puebla, Puebla, Mexico
    Acta Haematol 122:1-5. 2009
  5. ncbi Core binding factor acute myeloid leukemia (CBF-AML) in México: a single institution experience
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna de puebla, Clinica Ruiz, Puebla
    Rev Invest Clin 63:25-30. 2011
  6. doi Haploidentical Bone Marrow Transplantation in 2015 and Beyond
    Guillermo J Ruiz-Arguelles
    Clinica Ruiz, Centro de Hematologia y Medicina Interna de puebla, 8B Sur 3710, 72530, Puebla, Mexico
    Curr Oncol Rep 17:57. 2015
  7. doi Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin's lymphoma in a developing country?
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna, Clinica Ruiz, Puebla, Mexico
    Hematology 17:193-7. 2012
  8. doi Treatment of hairy cell leukemia: long-term results in a developing country
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna, Clinica Ruiz, Puebla, Mexico
    Hematology 17:140-3. 2012
  9. ncbi t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Hematology 11:235-8. 2006
  10. ncbi Transient mixed chimerism after stem cell transplantation can induce durable molecular complete remissions in chronic myelogenous leukemia
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Pue, Mexico
    Leuk Lymphoma 47:2590-2. 2006

Collaborators

  • Alejandro Ruiz-Arguelles
  • Eduardo Lobato-Mendizábal
  • Luis Benitez-Bribiesca
  • David Gomez-Almaguer
  • Briceida López-Martínez
  • Guillermo J Ruiz-Delgado
  • Javier Garces-Eisele
  • Sara Velazquez-Sanchez-de-Cima
  • Ana Hernandez-Arizpe
  • Avril López-Otero
  • Samantha Galindo-Becerra
  • Nancy Labastida-Mercado
  • Jesús Hernández-Reyes
  • Olga G Cantu-Rodriguez
  • Mónica León-González
  • Andres A León-Peña
  • Jaime Rosales-Padrón
  • Jessica García-Chavez
  • Gabriela Zamora-Ortiz
  • Mónica Patricia González-Ramírez
  • Nora Angela Martagón-Herrera
  • Luz C Tarín-Arzaga
  • Virginia Reyes-Núñez
  • Maryel Montes-Montiel
  • Julio Macías-Gallardo
  • Oscar Gonzalez-Llano
  • Julia Lutz-Presno
  • Laura N Rodríguez-Romo
  • Consuelo Mancias-Guerra
  • César H Gutiérrez-Aguirre
  • Martha L Gonzalez-Carrillo
  • Ana Karen Nuñez-Cortes
  • Andrés Gómez-de-León
  • María Fernanda Vallejo-Villalobos
  • Andrés A León Peña
  • Valeria Guzman-Olvera
  • Liliana Rivadeneyra-Espinoza
  • Elena Soto-Vega
  • Javier Anthon-Méndez
  • Daniel Arizpe-Bravo
  • Monica Dominguez-Cid
  • Perla Colunga-Pedraza
  • Angélica González-Cortés
  • Jocelyn Vargas-Espinosa
  • Danitza Fernández-Lara
  • Alan Daniel Rosales-Durón
  • Jackeline Calderón-Garcia
  • Omar Fernández-Vargas
  • Carlos Alarcón Urdaneta
  • Carlos Alarcón-Urdaneta
  • Mónica Sánchez-Cárdenas
  • Jacqueline Calderón-García
  • Uxmal Rodríguez-Morales
  • Alvaro Gómez-Peña
  • Sylvia Aide Martinez-Cabriales
  • María C Mancías-Guerra
  • Jose C Jaime-Perez
  • Oscar R Treviño-Montemayor
  • Sylvia A Martínez-Cabriales
  • Luz D C Tarín-Arzaga
  • Laura Nelly Rodriguez-Romo
  • Manuel Priesca-Marin
  • Karla I Gutiérrez-Riveroll
  • Edna L Tamez-Gómez
  • Renee Eyzaguirre-Zapata

Detail Information

Publications69

  1. ncbi Multiple myeloma in Mexico: a 20-year experience at a single institution
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Calle 8B Sur 3710, 72530 Puebla, Mexico
    Arch Med Res 35:163-7. 2004
    ..2% of all hematologic malignancies, whereas during this experience it was found to represent 7.7%. These figures contrast with those reported in Caucasians-10-15%...
  2. ncbi Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Am J Hematol 82:400-2. 2007
    ..Accordingly, the concept of "molecular remission" of the myelofibrosis with myeloid metaplasia could be entertained and added to the categories of response to treatment which have been recently described...
  3. ncbi Results of an autologous noncryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single-institution, 10-year experience
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Acta Haematol 110:179-83. 2003
    ..Methods to simplify the stem cell transplantation procedures are needed mainly in developing countries. We have previously shown that unprocessed leukapheresis material is useful to restore hematopoiesis after high-dose chemotherapy...
  4. doi Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna de puebla, Laboratorios Clinicos de Puebla, Puebla, Mexico
    Acta Haematol 122:1-5. 2009
    ..Two of the 3 cases had a dismal prognosis. A brief review of the literature is presented...
  5. ncbi Core binding factor acute myeloid leukemia (CBF-AML) in México: a single institution experience
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna de puebla, Clinica Ruiz, Puebla
    Rev Invest Clin 63:25-30. 2011
    ..Further studies are needed to describe with more detail the precise biological features of these molecular subtypes of acute leukemia...
  6. doi Haploidentical Bone Marrow Transplantation in 2015 and Beyond
    Guillermo J Ruiz-Arguelles
    Clinica Ruiz, Centro de Hematologia y Medicina Interna de puebla, 8B Sur 3710, 72530, Puebla, Mexico
    Curr Oncol Rep 17:57. 2015
    ..The improvement of the procedures to conduct haploidentical stem cell transplantation will most likely result in more individuals gaining access to this type of treatments, critical in the current practice of hematology. ..
  7. doi Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin's lymphoma in a developing country?
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna, Clinica Ruiz, Puebla, Mexico
    Hematology 17:193-7. 2012
    ..Since the addition of R results in a 36-fold increase in treatment costs, these observations may be important to decide therapeutic approaches in NHL patients living in underprivileged circumstances...
  8. doi Treatment of hairy cell leukemia: long-term results in a developing country
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna, Clinica Ruiz, Puebla, Mexico
    Hematology 17:140-3. 2012
    ..The data that we present here suggest that treatment of HCL with either 2-CDA or IFN is equally effective; treatment costs with IFN are substantially lower than those of the purine analog...
  9. ncbi t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Hematology 11:235-8. 2006
    ....
  10. ncbi Transient mixed chimerism after stem cell transplantation can induce durable molecular complete remissions in chronic myelogenous leukemia
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Pue, Mexico
    Leuk Lymphoma 47:2590-2. 2006
    ..A longer follow-up of the patients is mandatory to further clarify these observations...
  11. ncbi Second allogeneic peripheral blood stem cell transplants with reduced-intensity conditioning
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla
    Rev Invest Clin 58:34-8. 2006
    ..Conducting a second allograft may be useful to rescue some individuals relapsing after a first hematopoietic allotransplant...
  12. ncbi [Mexican medical journals]
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Clinica Ruiz de Puebla, Puebla, Mexico
    Gac Med Mex 142:125-37. 2006
  13. ncbi HFE-codon 63/282 (H63D/C282Y) gene variants in Mexican Mestizos are not risk factors for leukemia
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico Laboratorios Clínicos de Puebla, Puebla, Mexico
    Arch Med Res 37:65-7. 2006
    ..In some Caucasian populations it has been found that the C282Y hemochromatosis (HFE) gene mutation is a risk factor for the development of leukemia and other malignancies...
  14. ncbi The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter
    G J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Bone Marrow Transplant 36:1043-7. 2005
    ..The 100-day mortality was 4.4%, and transplant-related mortality was 8%. RIST for patients with CML in CP appears to be an adequate therapeutic option...
  15. ncbi Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Pue, Mexico
    Int J Hematol 82:262-5. 2005
    ..An EMR after allogeneic hematopoietic stem cell transplantation usually has a bad prognosis and presents mainly in individuals with high-risk malignancies...
  16. ncbi The Mexican approach to conduct allogeneic stem cell transplantation: braking dogmata and facing the Matthew effect
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna, Clinica Ruiz de Puebla, Puebla, Mexico
    Hematology 10:154-60. 2005
  17. ncbi Donor cell leukemia: a critical review
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna, Clinica Ruiz de Puebla, Puebla, Mexico
    Leuk Lymphoma 48:25-38. 2007
    ..Various mechanisms have been proposed to explain how DCL arise and are briefly discussed. Additional studies are needed to define with more detail both the true prevalence of this complication and its precise pathogenetic mechanism...
  18. ncbi Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Lab Hematol 13:22-6. 2007
    ....
  19. ncbi The Janus Kinase 2 (JAK2) V617F mutation in hematological malignancies in México
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla
    Rev Invest Clin 58:458-61. 2006
    ..Our data add to the observation that the JAK2 V617F mutation seems to be rather uncommon in myeloid malignancies other than the classic BCR/ABL negative MPD...
  20. doi Whither the bone marrow transplant?
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Pue, Mexico
    Hematology 15:1-3. 2010
    ..I will focus this discussion only on two diseases in which BMT has been shown to be useful: chronic myelogenous leukemia (CML) and multiple myeloma (MM)...
  21. doi Molecular characterization of chronic myeloproliferative neoplasias in México
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Mexico
    Hematology 14:261-5. 2009
    ..08). In the diagnosis and classification of the MPN, in addition to the newly identified molecular markers, clinical and laboratory data are still very important...
  22. doi Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?
    G J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna, Clinica Ruiz, Puebla, Mexico
    Bone Marrow Transplant 42:23-8. 2008
    ..Cost considerations favor allogeneic SCT as a 'once only' procedure whereas lifelong treatment with an expensive drug represents an excessive burden on resources...
  23. ncbi Alemtuzumab-induced resolution of refractory cutaneous chronic graft-versus-host disease
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Biol Blood Marrow Transplant 14:7-9. 2008
    ..The data presented here suggest that this agent may be useful in some patients with refractory forms of cGVHD...
  24. ncbi [Primary thrombophilia in México. VI: lack of statistical association among the inherited thrombophilic conditions]
    Guillermo J Ruiz-Arguelles
    Centro de Hematología y Medicina Intema de Puebla, Puebla, Mexico
    Gac Med Mex 143:317-22. 2007
    ..Over a 70-month period, 100 consecutive Mexican mestizo individuals with a clinical marker associated with a primary hypercoagulable state were studied...
  25. ncbi Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna, Clinica Ruiz de Puebla, Puebla, Mexico
    Hematology 12:387-91. 2007
    ..It may be postulated that the risk of higher MTX toxicity in patients with decreased MTHFR activity could be neutralized by the normally folate rich diet in Mexico...
  26. ncbi [Eight years using the "Mexican method" for allogeneic hematopoietic stem cell transplants]
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna, Clinica Ruiz de Puebla, Puebla, Mexico
    Gac Med Mex 143:231-5. 2007
    ....
  27. ncbi Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Pue, Mexico
    Hematology 12:255-6. 2007
    ..01). Our data support previous observations made in other countries about the ineffectiveness of oral IP in the treatment of individuals with IDA and should alert the clinician to avoid unnecessary consultations and misdiagnosis...
  28. ncbi Treatment of acute promyelocytic leukemia: a single institution experience
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla
    Rev Invest Clin 57:415-9. 2005
    ..The results are similar to those obtained in other centers worldwide and it is possible that the prophylactic administration of prednisone precluded the development of the full-blown ATRA syndrome in this group of patients...
  29. ncbi Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience
    G J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Pue, Mexico
    Bone Marrow Transplant 36:715-20. 2005
    ..We conclude that, by using certain preparative regimens, both allo and auto hematopoietic stem cell grafts can be conducted without the transfusion of blood products...
  30. ncbi Gilbert's syndrome disclosed during the treatment of hematological malignancies
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico, Mexico
    Hematology 10:59-60. 2005
    ..Bilirubin levels returned to normal in all five patients following treatment. GS should not be overlooked in individuals exposed to these treatments who develop hyperbilirubinemia and jaundice...
  31. ncbi More on geographic hematology: the breakpoint cluster regions of the PML/RARalpha fusion gene in Mexican Mestizo patients with promyelocytic leukemia are different from those in Caucasians
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Mexico
    Leuk Lymphoma 45:1365-8. 2004
    ....
  32. ncbi Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed Hodgkin's disease following autologous stem cell transplantation
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Laboratorios Clinicos de Puebla, Puebla, Mexico
    Arch Med Res 34:242-5. 2003
    ..Further follow-up and evaluation of additional patients are required to conclusively establish the role of this strategy in treatment of hematologic malignancies after autologous transplantation...
  33. ncbi Long-term results of the immunosuppressive treatment of patients with severe acquired aplastic anemia: a single institution study
    Guillermo J Ruiz-Arguelles
    Centro de Hematología y Medicina Interna de Puebla and Laboratorios Clínicos de Puebla, Puebla, Mexico
    Acta Haematol 110:184-7. 2003
    ..IS was a good therapeutic choice for some patients with SAA, clearly better than androgen treatment...
  34. ncbi Non-myeloablative bone marrow transplantation
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna, Clinica Ruiz de Puebla, Puebla, Mexico
    Arch Med Res 34:554-7. 2003
    ..Breaking all these dogmata has resulted in availability of HSC allografting to a larger number of individuals, thus offering true curative therapeutic options to patients who otherwise would not qualify to receive these opportunities...
  35. ncbi [Graft vs. tumor effect in chronic granulocytic leukemia]
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna, Clinica Ruiz de Puebla, Pue
    Rev Invest Clin 54:154-60. 2002
  36. ncbi Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: a prospective study
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Mexico
    Leuk Lymphoma 45:1191-5. 2004
    ..The 100-day and the transplant-related mortality were both 8%. NST appears to be an effective additional therapeutic option for patients with AML in remission and a matched donor available...
  37. ncbi Breaking dogmata to help patients: non-myeloablative haematopoietic stem cell transplantation
    Guillermo J Ruiz-Arguelles
    Clinica Ruiz de Puebla, Centro de Hematologia y Medicina Interna, 8B Sur 3710, 72530, Puebla, Mexico
    Expert Opin Biol Ther 4:1693-9. 2004
    ....
  38. ncbi [Importance of chimerism in medicine]
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Laboratorios Clinicos de Puebla
    Gac Med Mex 140:573-5. 2004
  39. ncbi Primary thrombophilia in Mexico III: A prospective study of the sticky platelet syndrome
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Mexico
    Clin Appl Thromb Hemost 8:273-7. 2002
    ..All patients were treated with aspirin and no new vasoocclusive episodes have been recorded. SPS in not an infrequent finding in Mexican mestizo thrombophilic patients and may contribute to thrombophilia...
  40. ncbi Primary thrombophilia in Mexico. V. A comprehensive prospective study indicates that most cases are multifactorial
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Am J Hematol 78:21-6. 2005
    ..The results are consonant with the idea that most cases of thrombophilia in Mexico are multifactorial...
  41. ncbi Significance of one human leukocyte antigen mismatch on outcome of nonmyeloablative allogeneic stem cell transplantation from related donors using the Mexican schedule
    G J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Mexico
    Bone Marrow Transplant 35:335-9. 2005
    ..It seems that NST can be offered to individuals with either an HLA identical or a compatible sibling donor...
  42. ncbi Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican Mestizo patients
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Mexico
    Rev Invest Clin 56:600-4. 2004
    ....
  43. ncbi Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Mexico
    Rev Invest Clin 56:605-8. 2004
    ..These data are not different from those previously described in other populations and are consonant with the prevalence of chronic myelogenous leukemia in Mexico, which is not different from that described in other populations...
  44. ncbi Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, 8B Sur 3710, 72530 Puebla, Pue, Mexico
    Haematologica 87:894-6. 2002
  45. ncbi No cytomegalovirus-related deaths after non-ablative stem cell allografts
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Pue, Mexico
    Hematology 7:95-9. 2002
    ....
  46. ncbi Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Hematology 8:151-4. 2003
    ..The possibility of conducting allografts without transfusion of blood products in some patients may result in a decrease in both cost and the risks stemming from exposure to human blood derivatives...
  47. pmc A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna de puebla, 8B Sur 3710, 72530 Puebla, PUE Mexico
    Blood Transfus 7:127-31. 2009
    ....
  48. doi Long-term results of placental blood allografting using reduced-intensity conditioning: multicenter experience in a developing country
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Hematology 16:155-9. 2011
    ..Placental blood (PLB) hematopoietic stem cell transplantation has recently been explored in an increasing number of patients; the best conditioning regimen has not been established...
  49. ncbi Follow up of hemopoietic chimerism in individuals given allogeneic hemopoietic stem cell allografts using an immunosuppressive, non-myeloablative conditioning regimen: a prospective study in a single institution
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Mexico
    Leuk Lymphoma 43:1509-11. 2002
    ....
  50. doi Primary thrombophilia in México VII: the V617F mutation of JAK2 is not a frequent cause of thrombosis
    Javier Garces-Eisele
    Laboratorios Clinicos de Puebla, Puebla, Mexico
    Hematology 13:244-6. 2008
    ....
  51. doi Low incidence and severity of graft-versus-host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced-intensity conditioning
    Olga G Cantu-Rodriguez
    Hospital Universitario Dr José Eleuterio González, Universidad Autonoma de Nuevo Leon, Monterrey
    Eur J Haematol 87:521-30. 2011
    ..Several features of GVHD in patients at two institutions using RIC were assessed...
  52. ncbi An addition to geographic hematology: chronic myeloproliferative diseases are infrequent in Mexican Mestizos
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Pue, Mexico
    Int J Hematol 75:499-502. 2002
    ..Data indicate that the prevalence of CML in our country is similar to that found in Caucasians; however, the prevalence of the other CMPDs has not been studied...
  53. ncbi Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: results of the Mexican approach
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna, Clinica Ruiz de Puebla, Mexico
    Int J Hematol 76:376-9. 2002
    ..2%. The median cost of the allografts was 18,000.00 US dollars. This method could be particularly adequate in developing countries, where very few individuals can afford the cost of a conventional bone marrow transplantation procedure...
  54. doi The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience
    Avril López-Otero
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Hematology 15:378-81. 2010
    ....
  55. ncbi [Donor cell leukemia (DCL): A prospective study of its identification and treatment]
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna, Clinica Ruiz de Puebla, Puebla, Pue, Mexico
    Gac Med Mex 151:582-7. 2015
    ..It is possible to obtain favorable responses in donor cell leukemia patients employing combined chemotherapy. The long-term donor cell leukemia survivors remain as full chimeras and have not needed a second transplant. ..
  56. ncbi The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease
    Guillermo J Ruiz-Arguelles
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Am J Hematol 75:200-4. 2004
    ..CMV reactivation, disease, and mortality were very low using our non-myeloablative stem cell transplantation schedule, which has been shown to be useful for allografting with minimal toxicity and reduced costs...
  57. doi Primary thrombophilia in México X: a prospective study of the treatment of the sticky platelet syndrome
    Sara Velazquez-Sanchez-de-Cima
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico Laboratorios Clínicos de Puebla, Diaz Ordaz 808, Puebla, México Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Santiago, Puebla, Mexico
    Clin Appl Thromb Hemost 21:91-5. 2015
    ..The sticky platelet syndrome (SPS) is a common cause of thrombosis. There are no prospective studies concerning treatment...
  58. doi The mutation profile of JAK2, MPL and CALR in Mexican patients with Philadelphia chromosome-negative myeloproliferative neoplasms
    Nancy Labastida-Mercado
    Centro de Hematologia y Medicina Interna de puebla, Mexico Universidad Popular Autónoma del Estado de Puebla, Mexico
    Hematol Oncol Stem Cell Ther 8:16-21. 2015
    ..By using molecular markers, it is possible to gain information on both the classification and etiopathogenesis of chronic myeloproliferative neoplasias (MPN)...
  59. doi Outcome of Recipients of Hematopoietic Stem Cell Transplants Who Require Intensive Care Unit Support: A Single Institution Experience
    Samantha Galindo-Becerra
    Centro de Hematologia y Medicina Interna, Clinica Ruiz, Puebla, Mexico
    Acta Haematol 134:119-24. 2015
    ....
  60. doi Romiplostin may revert the thrombocytopenia in graft-versus-host disease
    Guillermo J Ruiz-Delgado
    Laboratorios Clinicos de Puebla, Mexico
    Hematology 16:108-9. 2011
    ..To the best of our knowledge, this is the first description of the usefulness of the peptibody in the setting of GVHD...
  61. ncbi Apoptosis of melanocytes in vitiligo results from antibody penetration
    Alejandro Ruiz-Arguelles
    Department of Immunology, Laboratorios Clinicos de Puebla, Diaz Ordaz 808, Puebla, PUE 72530, Mexico
    J Autoimmun 29:281-6. 2007
    ..Our results are consonant with the theory that melanocyte-specific antibodies are responsible for the deletion of melanocytes through antibody penetration and apoptosis...
  62. ncbi The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias
    Alejandro Ruiz-Arguelles
    Department of Immunology, Laboratorios Clinicos de Puebla, Diaz Ordaz 808, Puebla, PUE 72530, Mexico
    Autoimmun Rev 6:155-61. 2007
    ..Although autoantibodies appeal as the best candidates to cause underexpression of CD55 and CD59, the search for an association to the presence and titers of most frequent self-reactive antibodies has proved non-existent...
  63. ncbi Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies
    Alejandro Ruiz-Arguelles
    Laboratorios Clinicos de Puebla, Mexico
    Cytometry B Clin Cytom 70:39-44. 2006
    ..The aim of disseminating these guidelines to the international community is based on the potential interest for other countries with similar socioeconomic conditions...
  64. doi A Mexican way to cope with stem cell grafting
    Guillermo J Ruiz-Delgado
    Centro de Hematologia y Medicina Interna de puebla, Clinica Ruiz, Puebla, Mexico
    Hematology 17:S195-7. 2012
    ....
  65. ncbi Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and Transplantation
    Mónica León-González
    Centro de Hematologia y Medicina Interna de puebla, Clinica Ruiz, Puebla, Mexico
    Rev Invest Clin 68:181-3. 2016
    ..Following the release of the initial presentation of filgrastim (granulocyte colony-stimulating factor), several biosimilars have been developed worldwide...
  66. ncbi Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications
    Alejandro Ruiz-Arguelles
    Department of Immunology, Laboratorios Clinicos de Puebla, Mexico
    Curr Pharm Des 9:1881-7. 2003
    ..Increasing interest is being paid to the potential immunotherapeutic role of penetrating antibodies as tools to deliver drugs, isotopes or genes into cells...
  67. doi Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report
    Guillermo J Ruiz-Delgado
    a Centro de Hematología y Medicina Interna, Clinica Ruiz, Mexico
    Hematology 21:470-3. 2016
    ..Here we describe a case of a 27-year-old woman with a diagnosis of biphenotypic acute leukemia who received a HSCT and developed a DCL. We briefly discuss the possible pathogenesis, diagnosis, and treatment of DCL. ..
  68. doi Oral versus intravenous fludarabine as part of a reduced-intensity conditioning for allogeneic stem cell transplantation
    Sara Velazquez-Sanchez-de-Cima
    Centro de Hematologia y Medicina Interna, Clinica Ruiz, Puebla, Mexico
    Acta Haematol 132:125-8. 2014
    ..v. formulation was withdrawn. Accordingly, i.v. fludarabine had to be replaced by oral fludarabine as part of the conditioning regimen employed to conduct allogeneic stem cell transplantation in México...
  69. ncbi A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia
    Eduardo Lobato-Mendizábal
    Centro de Hematologia y Medicina Interna de puebla, Puebla, Mexico
    Rev Invest Clin 55:31-5. 2003
    ..After identifying these variables as important, imaginative approaches to the treatment of cancer in childhood in the years ahead may lead into the improvement of the results of these treatments...